MedDataX Logo

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT ID: NCT01061567

Last Updated: 2014-07-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1814 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-11-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The general aim of this non-interventional study is to assess the safety and efficacy of pramipexole extended release in patients with Parkinson's disease in routine clinical practice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

NCT00577460

Parkinson Disease
COMPLETED PHASE3

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523

Parkinson Disease
COMPLETED PHASE3

Pivotal Study in Advanced Parkinsons Disease Patients

NCT00466167

Parkinson Disease
COMPLETED PHASE3

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

NCT01361009

Parkinson Disease
COMPLETED

A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period

NCT00560508

Parkinson Disease
COMPLETED PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Male and female patients with Parkinson's disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Early and advanced idiopathic Parkinson's disease
* Male and female patients over 18 years of age
* Indication for treatment with pramipexole ER according to Summary of Product Characteristics (SmPC)

Exclusion Criteria

* Ongoing treatment with pramipexole ER

In particular hypersensitivity to pramipexole or to any of the excipients and pregnancy and lactation as stated in the SmPC.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 1

Bad Ischl, , Austria

Site Status

Boehringer Ingelheim Investigational Site 2

Bad Radkersburg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 3

Baden, , Austria

Site Status

Boehringer Ingelheim Investigational Site 4

Baden, , Austria

Site Status

Boehringer Ingelheim Investigational Site 5

Bludenz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 6

Braunau/Inn, , Austria

Site Status

Boehringer Ingelheim Investigational Site 7

Deutschlandsberg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 8

Dornbirn, , Austria

Site Status

Boehringer Ingelheim Investigational Site 9

Dornbirn, , Austria

Site Status

Boehringer Ingelheim Investigational Site 10

Ehenbichl, , Austria

Site Status

Boehringer Ingelheim Investigational Site 11

Eisenstadt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 12

Eisenstadt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 13

Feldbach, , Austria

Site Status

Boehringer Ingelheim Investigational Site 14

Feldkirchen in Kärnten, , Austria

Site Status

Boehringer Ingelheim Investigational Site 15

Gänserndorf, , Austria

Site Status

Boehringer Ingelheim Investigational Site 16

Graz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 17

Graz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 18

Graz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 19

Graz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 20

Grieskirchen, , Austria

Site Status

Boehringer Ingelheim Investigational Site 21

Grimmenstein, , Austria

Site Status

Boehringer Ingelheim Investigational Site 22

Hainburg an der Donau, , Austria

Site Status

Boehringer Ingelheim Investigational Site 23

Hall/Tirol, , Austria

Site Status

Boehringer Ingelheim Investigational Site 24

Hallein, , Austria

Site Status

Boehringer Ingelheim Investigational Site 25

Hartberg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 26

Hermagor, , Austria

Site Status

Boehringer Ingelheim Investigational Site 27

Hohenems, , Austria

Site Status

Boehringer Ingelheim Investigational Site 28

Horn, , Austria

Site Status

Boehringer Ingelheim Investigational Site 29

Horn, , Austria

Site Status

Boehringer Ingelheim Investigational Site 30

Imst, , Austria

Site Status

Boehringer Ingelheim Investigational Site 31

Innsbruck, , Austria

Site Status

Boehringer Ingelheim Investigational Site 32

Innsbruck, , Austria

Site Status

Boehringer Ingelheim Investigational Site 33

Innsbruck, , Austria

Site Status

Boehringer Ingelheim Investigational Site 34

Judenburg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 35

Kapfenberg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 36

Klagenfurt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 37

Klagenfurt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 38

Klagenfurt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 39

Klagenfurt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 40

Knittelfeld, , Austria

Site Status

Boehringer Ingelheim Investigational Site 41

Krems, , Austria

Site Status

Boehringer Ingelheim Investigational Site 42

Kufstein, , Austria

Site Status

Boehringer Ingelheim Investigational Site 43

Lassnitzhöhe, , Austria

Site Status

Boehringer Ingelheim Investigational Site 44

Leibnitz, Styria, , Austria

Site Status

Boehringer Ingelheim Investigational Site 45

Leoben, , Austria

Site Status

Boehringer Ingelheim Investigational Site 46

Lienz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 47

Lienz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 48

Lilienfeld, , Austria

Site Status

Boehringer Ingelheim Investigational Site 49

Linz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 50

Linz, , Austria

Site Status

Boehringer Ingelheim Investigational Site 51

Melk, , Austria

Site Status

Boehringer Ingelheim Investigational Site 52

Mürzzuschlag, , Austria

Site Status

Boehringer Ingelheim Investigational Site 53

Neulengbach, , Austria

Site Status

Boehringer Ingelheim Investigational Site 54

Neulengbach, , Austria

Site Status

Boehringer Ingelheim Investigational Site 55

Neunkirchen, , Austria

Site Status

Boehringer Ingelheim Investigational Site 56

Neunkirchen, , Austria

Site Status

Boehringer Ingelheim Investigational Site 57

Neusiedl am See, , Austria

Site Status

Boehringer Ingelheim Investigational Site 58

Oberwart, , Austria

Site Status

Boehringer Ingelheim Investigational Site 59

Oberwart, , Austria

Site Status

Boehringer Ingelheim Investigational Site 60

Oberwart, , Austria

Site Status

Boehringer Ingelheim Investigational Site 61

Regelsbrunn, , Austria

Site Status

Boehringer Ingelheim Investigational Site 62

Ried im Innkreis, , Austria

Site Status

Boehringer Ingelheim Investigational Site 63

Ried im Innkreis, , Austria

Site Status

Boehringer Ingelheim Investigational Site 64

Rohrbach, , Austria

Site Status

Boehringer Ingelheim Investigational Site 65

Salzburg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 66

Salzburg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 67

Salzburg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 68

Salzburg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 71

Sankt Pölten, , Austria

Site Status

Boehringer Ingelheim Investigational Site 72

Sankt Pölten, , Austria

Site Status

Boehringer Ingelheim Investigational Site 73

Sankt Veit an der Glan, , Austria

Site Status

Boehringer Ingelheim Investigational Site 69

Scheibbs, , Austria

Site Status

Boehringer Ingelheim Investigational Site 70

St Johann im Pongau, , Austria

Site Status

Boehringer Ingelheim Investigational Site 74

Telfs, , Austria

Site Status

Boehringer Ingelheim Investigational Site 75

Tulln, , Austria

Site Status

Boehringer Ingelheim Investigational Site 76

Tullnerbach-Lawies, , Austria

Site Status

Boehringer Ingelheim Investigational Site 100

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 101

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 102

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 103

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 104

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 105

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 106

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 107

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 84

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 85

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 86

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 87

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 88

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 89

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 90

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 91

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 92

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 93

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 94

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 95

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 96

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 97

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 98

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 99

Vienna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 77

Villach, , Austria

Site Status

Boehringer Ingelheim Investigational Site 78

Villach, , Austria

Site Status

Boehringer Ingelheim Investigational Site 79

Villach-Warmbad, , Austria

Site Status

Boehringer Ingelheim Investigational Site 80

Vöcklabruck, , Austria

Site Status

Boehringer Ingelheim Investigational Site 81

Vöcklabruck, , Austria

Site Status

Boehringer Ingelheim Investigational Site 82

Völkermarkt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 83

Wagna, , Austria

Site Status

Boehringer Ingelheim Investigational Site 108

Wiener Neustadt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 109

Wolfsberg, , Austria

Site Status

Boehringer Ingelheim Investigational Site 110

Zirl, , Austria

Site Status

Boehringer Ingelheim Investigational Site 111

Zwettl Stadt, , Austria

Site Status

Boehringer Ingelheim Investigational Site 115

Järvamaa, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 114

Kohtla-Järve, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 121

Kuressaare, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 116

Rakvere, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 112

Tallinn, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 113

Tallinn, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 117

Tartu, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 118

Valga, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 119

Viimsi, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 120

Viljandi, , Estonia

Site Status

Boehringer Ingelheim Investigational Site 283

Almaty, , Kazakhstan

Site Status

Boehringer Ingelheim Investigational Site 284

Astana, , Kazakhstan

Site Status

Boehringer Ingelheim Investigational Site 282

Shymkent, , Kazakhstan

Site Status

Boehringer Ingelheim Investigational Site 193

Alba Iulia, , Romania

Site Status

Boehringer Ingelheim Investigational Site 194

Bacau, , Romania

Site Status

Boehringer Ingelheim Investigational Site 195

Bacau, , Romania

Site Status

Boehringer Ingelheim Investigational Site 196

Bacau, , Romania

Site Status

Boehringer Ingelheim Investigational Site 197

Baia Mare, , Romania

Site Status

Boehringer Ingelheim Investigational Site 198

Baia Mare, , Romania

Site Status

Boehringer Ingelheim Investigational Site 199

Botoșani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 200

Brasov, , Romania

Site Status

Boehringer Ingelheim Investigational Site 201

Brasov, , Romania

Site Status

Boehringer Ingelheim Investigational Site 202

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 203

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 204

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 205

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 206

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 207

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 208

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 209

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 210

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 211

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 212

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 213

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 214

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 215

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 216

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 217

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 218

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 219

Bucharest, , Romania

Site Status

Boehringer Ingelheim Investigational Site 220

Buzău, , Romania

Site Status

Boehringer Ingelheim Investigational Site 221

Buzău, , Romania

Site Status

Boehringer Ingelheim Investigational Site 222

Campulung Muscel, , Romania

Site Status

Boehringer Ingelheim Investigational Site 223

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 224

Cluj-Napoca, , Romania

Site Status

Boehringer Ingelheim Investigational Site 225

Constanța, , Romania

Site Status

Boehringer Ingelheim Investigational Site 226

Constanța, , Romania

Site Status

Boehringer Ingelheim Investigational Site 227

Constanța, , Romania

Site Status

Boehringer Ingelheim Investigational Site 228

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 229

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 230

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 231

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 232

Craiova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 233

Curtea de Argeş, , Romania

Site Status

Boehringer Ingelheim Investigational Site 234

Focşani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 235

Focşani, , Romania

Site Status

Boehringer Ingelheim Investigational Site 236

Galati, , Romania

Site Status

Boehringer Ingelheim Investigational Site 237

Iași, , Romania

Site Status

Boehringer Ingelheim Investigational Site 238

Iași, , Romania

Site Status

Boehringer Ingelheim Investigational Site 239

Iași, , Romania

Site Status

Boehringer Ingelheim Investigational Site 240

Medgidia, , Romania

Site Status

Boehringer Ingelheim Investigational Site 241

Oradea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 242

Oradea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 243

Piatra Neamţ, , Romania

Site Status

Boehringer Ingelheim Investigational Site 244

Piatra Neamţ, , Romania

Site Status

Boehringer Ingelheim Investigational Site 245

Piteşti, , Romania

Site Status

Boehringer Ingelheim Investigational Site 246

Piteşti, , Romania

Site Status

Boehringer Ingelheim Investigational Site 247

Ploieşti, , Romania

Site Status

Boehringer Ingelheim Investigational Site 248

Prahova, , Romania

Site Status

Boehringer Ingelheim Investigational Site 249

Radauti, , Romania

Site Status

Boehringer Ingelheim Investigational Site 250

Râmnicu Vâlcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 251

Râmnicu Vâlcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 252

Râmnicu Vâlcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 253

Satu Mare, , Romania

Site Status

Boehringer Ingelheim Investigational Site 254

Satu Mare, , Romania

Site Status

Boehringer Ingelheim Investigational Site 255

Sibiu, , Romania

Site Status

Boehringer Ingelheim Investigational Site 256

Sibiu, , Romania

Site Status

Boehringer Ingelheim Investigational Site 257

Simleul Silvaniei, , Romania

Site Status

Boehringer Ingelheim Investigational Site 258

Slobozia, , Romania

Site Status

Boehringer Ingelheim Investigational Site 259

Suceava, , Romania

Site Status

Boehringer Ingelheim Investigational Site 260

Târgovişte, , Romania

Site Status

Boehringer Ingelheim Investigational Site 261

Târgovişte, , Romania

Site Status

Boehringer Ingelheim Investigational Site 262

Târgu Mureş, , Romania

Site Status

Boehringer Ingelheim Investigational Site 263

Târnăveni, , Romania

Site Status

Boehringer Ingelheim Investigational Site 264

Târnăveni, , Romania

Site Status

Boehringer Ingelheim Investigational Site 265

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 266

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 267

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 268

Timișoara, , Romania

Site Status

Boehringer Ingelheim Investigational Site 269

Tulcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 270

Tulcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 271

Tulcea, , Romania

Site Status

Boehringer Ingelheim Investigational Site 272

Turda, , Romania

Site Status

Boehringer Ingelheim Investigational Site 273

Turnu Măgurele, , Romania

Site Status

Boehringer Ingelheim Investigational Site 274

Zalău, , Romania

Site Status

Boehringer Ingelheim Investigational Site 275

Belgrade, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 276

Belgrade, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 278

Kragujevac, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 281

Kraljevo, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 279

Niš, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 277

Novi Sad, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 280

Užice, , Serbia

Site Status

Boehringer Ingelheim Investigational Site 122

Banská Bystrica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 123

Bardejov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 124

Bardejov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 125

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 126

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 127

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 128

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 129

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 130

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 131

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 132

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 133

Brezno, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 134

Detva, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 135

Dolný Kubín, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 136

Dolný Kubín, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 137

Hlohovec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 138

Hlohovec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 139

Humenné, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 140

Kežmarok, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 141

Kežmarok, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 142

Komárno, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 143

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 144

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 145

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 146

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 147

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 148

Krompachy, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 149

Liptovský Mikulás, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 150

Lučenec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 151

Lučenec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 152

Lučenec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 153

Martin, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 154

Martin, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 155

Myjava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 156

Námestovo, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 157

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 158

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 159

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 160

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 161

Pezinok, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 162

Piešťany, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 163

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 164

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 165

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 166

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 169

Skalica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 170

Stará Lubovna, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 167

Šahy, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 168

Šaľa, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 171

Šurany, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 172

Topoľčany, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 173

Trebišov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 174

Trencín, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 175

Trnava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 176

Trnava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 177

Trstená, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 178

Vranov Nad Top?ou, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 182

Zlaté Moravce, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 181

Zvolen, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 179

Žiar nad Hronom, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 180

Žilina, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 183

Celje, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 184

Lesce, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 185

Ljubljana, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 186

Ljubljana, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 187

Maribor, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 188

Maribor, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 190

Sempeter, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 191

Sempeter, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 189

Slovenj Gradec, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 192

Velenje, , Slovenia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Estonia Kazakhstan Romania Serbia Slovakia Slovenia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

248.675

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease
NCT01097421 COMPLETED
Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients
NCT02177357 COMPLETED PHASE3
Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
NCT00479401 COMPLETED PHASE3
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
NCT01096186 COMPLETED PHASE3
Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life
NCT01100073 COMPLETED
Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease
NCT00240409 COMPLETED PHASE3
Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease
NCT01673724 COMPLETED PHASE4
Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms
NCT00297778 COMPLETED PHASE4
A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
NCT01711866 COMPLETED PHASE4
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
NCT03100149 ACTIVE_NOT_RECRUITING PHASE2
Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole
NCT02236728 COMPLETED
Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease
NCT00558025 COMPLETED PHASE3
SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease
NCT00335166 COMPLETED PHASE3
Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole
NCT00615914 COMPLETED
The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease
NCT01470859 COMPLETED NA
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
NCT01723904 COMPLETED PHASE3
A Study to Evaluate in Patients With Parkinsonian Type Disorders
NCT03683225 ACTIVE_NOT_RECRUITING PHASE2
Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients
NCT01191944 COMPLETED PHASE3
Bioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male Volunteers
NCT02261103 COMPLETED PHASE1
Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease
NCT02172573 COMPLETED PHASE3
The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa
NCT03521635 COMPLETED PHASE4
Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease
NCT02233023 COMPLETED PHASE4
An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease
NCT00505687 COMPLETED PHASE3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310 RECRUITING PHASE3
Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease
NCT00539214 COMPLETED